ArticleInternal medicine (Tokyo, Japan)2026
Urinary β2-microglobulin as a Potential Biomarker for Early Treatment Selection: A Patient with Severe IgG4-related Tubulointerstitial Nephritis.
Nozomi Taniguchi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.